Inventor · disambiguated record
Edward J. Olhava
Also filed as: OLHAVA EDWARD J · OLHAVA EDWARD JAMES
45 granted patents·47 pending applications·563 citations·filing 2006–2023
98Inventor score
Files withEPIZYME INC39MILLENNIUM PHARM INC29INNATE TUMOR IMMUNITY INC11LANGSTON STEVEN P3TAKEDA PHARMACEUTICALS CO3
Top patents by PatentIndex Score
92 records- 0199US9206157B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Dec 8, 2015·28 cites·14 claims
- 0299US8962620B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Feb 24, 2015·31 cites·10 claims
- 0399US8598167B1Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Dec 3, 2013·34 cites·12 claims
- 0498US7442830B1Proteasome inhibitorsMILLENIUM PHARMACEUTICALS INC·Filed 2007·Granted Oct 28, 2008·96 cites·10 claims
- 0597US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0697US8003819B2Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2010·Granted Aug 23, 2011·27 cites·3 claims
- 0796US7687662B2Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted Mar 30, 2010·16 cites·4 claims
- 0895US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0994US10968247B2Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2019·Granted Apr 6, 2021·4 cites·20 claims
- 1094US10273223B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2017·Granted Apr 30, 2019·5 cites·13 claims
- 1194US9637472B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted May 2, 2017·16 cites·19 claims
- 1294US9150525B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2014·Granted Oct 6, 2015·10 cites·19 claims
- 1394US8722877B27-deazapurine modulators of histone methyltransferase, and methods of use thereofEPIZYME INC·Filed 2013·Granted May 13, 2014·19 cites·12 claims
- 1494US8580762B2Substituted purine and 7-deazapurine compoundsOLHAVA EDWARD JAMES·Filed 2011·Granted Nov 12, 2013·37 cites·6 claims
- 1594US8530694B2Proteasome inhibitorsOLHAVA EDWARD J·Filed 2011·Granted Sep 10, 2013·12 cites·4 claims
- 1693US10604542B2Cyclic dinucleotides for treating conditions associated with sting activity such as cancerINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 1793US10556903B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Feb 11, 2020·12 cites·5 claims
- 1893US10112968B2Inhibitors of protein methyltransferase DOT1L and methods of use thereofEPIZYME INC·Filed 2016·Granted Oct 30, 2018·5 cites·14 claims
- 1993US9096634B2Substituted purine and 7-deazapurine compoundsEPIZYME INC·Filed 2013·Granted Aug 4, 2015·17 cites·20 claims
- 2093US8901136B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·12 cites·9 claims
- 2192US10881680B2Method of treating leukemiaEPIZYME INC·Filed 2018·Granted Jan 5, 2021·3 cites·20 claims
- 2292US10533005B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted Jan 14, 2020·9 cites·41 claims
- 2392US9597348B2Method of treating leukemiaEPIZYME INC·Filed 2013·Granted Mar 21, 2017·15 cites·18 claims
- 2492US8207177B2Inhibitors of E1 activating enzymesLANGSTON STEVEN P·Filed 2007·Granted Jun 26, 2012·26 cites·9 claims
- 2592US7951810B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2006·Granted May 31, 2011·16 cites·19 claims
- 2691US9145438B27-deazapurine modulators of histone methyltransferase, and methods of use thereofCHESWORTH RICHARD·Filed 2011·Granted Sep 29, 2015·18 cites·20 claims
- 2790US9029343B2Modulators of histone methyltransferase, and methods of use thereofCHESWORTH RICHARD·Filed 2011·Granted May 12, 2015·18 cites·24 claims
- 2890US2024083922A1Proteasome InhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2989US10961270B2Compounds and compositions for treating conditions associated with sting activityINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Mar 30, 2021·2 cites·7 claims
- 3089US9175032B2Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2014·Granted Nov 3, 2015·6 cites·20 claims
- 3189US8871745B2Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2013·Granted Oct 28, 2014·3 cites·25 claims
- 3288US9458108B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2015·Granted Oct 4, 2016·3 cites·18 claims
- 3388US2023265110A1Proteasome InhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 3486US9701707B2Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2015·Granted Jul 11, 2017·3 cites·15 claims
- 3586US2023287033A1Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2022·Application pending·0 cites
- 3685US12351580B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2023·Granted Jul 8, 2025·0 cites·6 claims
- 3783US2022251117A1Proteasome inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 3881US9738679B2Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2014·Granted Aug 22, 2017·2 cites·20 claims
- 3980US11753433B2Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2021·Granted Sep 12, 2023·0 cites·12 claims
- 4080US2022017542A1Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 4178US11072612B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 27, 2021·1 cites·5 claims
- 4278US2021206784A1Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 4377US11572383B2Methods of synthesizing substituted purine compoundsEPIZYME INC·Filed 2020·Granted Feb 7, 2023·0 cites·5 claims
- 4477US9394310B2Carbocycle-substituted purine and 7-deazapurine compoundsOLHAVA EDWARD J·Filed 2011·Granted Jul 19, 2016·4 cites·37 claims
- 4577US7838673B2Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2007·Granted Nov 23, 2010·3 cites·10 claims
- 4676US2020407376A1Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 4775US8772536B2Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2013·Granted Jul 8, 2014·1 cites·42 claims
- 4874US11633420B2Method of treating leukemiaEPIZYME INC·Filed 2021·Granted Apr 25, 2023·0 cites·13 claims
- 4974US2015011506A1Proteasome InhibitorsMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 5074US2020190118A1Proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →